Plain-English translation of NCT06082492 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Stage III non-small cell lung cancer often comes back during follow-up care. This study is testing whether a special imaging scan called 18F FDG PET/CT can catch cancer recurrence earlier than standard CT scans alone. Finding recurrence earlier might allow doctors to treat it when it's still treatable with curative intent.
Right now, doctors use standard CT scans to monitor patients for cancer recurrence during follow-up. However, many patients develop recurrence that may be caught too late for curative treatment. This study explores whether the advanced PET/CT scan can detect cancer coming back sooner, when treatment with curative intent is still possible, which could improve survival and quality of life.
You likely qualify if…
You likely don't qualify if…
If you join, you'll be randomly assigned to one of two groups. One group receives standard follow-up care with regular CT scans every 6 months for 2 years, then yearly scans through year 3. The other group receives the same standard care plus extra advanced PET/CT scans at 6, 12, 18, 24, and 36 months. You'll also complete surveys about your quality of life and experience with the scans. The study follows you for 3 years.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Netherlands